Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Actithera to secure $75.5 million Series A financing round co-led by M Ventures, Hadean Ventures, Sofinnova Partners, and 4BIO Capital

Actithera to secure $75.5 million Series A financing round co-led by M Ventures, Hadean Ventures, Sofinnova Partners, and 4BIO Capital

AI (big data) Biotech Health services Software Services

Finland

Norway

France

United Kingdom

Netherlands

United States

Israel

Belgium

Investments

01 July 2025

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Actithera (company)

Norway

AI (big data)Biotech Health services Software Services

Total investments received (USD): 75.5M

Round value (USD): 75.5M

Round investors: Sofinnova Partners Investinor 4BIO Capital Innovestor Ventures Merck Ventures Surveyor Capital Hadean Ventures Bioqube Ventures Arkin Digital Health

Company: Actithera

Industry: AI (big data)Biotech Health services Software Services

Related deals

Immutrin in a £65M series A led by Frazier Life Sciences, joined by SR One, Qiming Venture Partners, Cambridge Enterprise Ventures and F-Prime

Biotech Health services Manufacturing Pharma

United Kingdom

United States

Investments 07 March 2026

Oncomatryx raised $67 million with CDTI, BBK, Ekarpen and investors in Spain

Biotech Health services Pharma

Spain

Investments 03 March 2026

Polares Medical secures $50 million Series C financing with DC Global Ventures, Lumination Partners

Biotech Health services

Switzerland

Germany

United Kingdom

United States

Investments 01 March 2026

Vitestro raised a $70 million Series B round with Labcorp Venture, Mayo Clinic, Sutter Health, InterVest, MGFO, PGGM, Puma Venture Capital and ROM Utrecht

Health services Manufacturing Software Services

United Kingdom

Netherlands

United States

Belgium

South Korea

Investments 01 March 2026

R1 Therapeutics secured a $77.5 million Series A led by Abingworth, F-Prime Capital and DaVita Venture Group.

Biotech Health services Pharma

United Kingdom

United States

Investments 01 March 2026

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top